RASSF4 Attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease Progression via Hippo Signaling and Suppresses Hepatocarcinogenesis

This publication has 50 references indexed in Scilit:

• PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II
  Cell Reports, 2022
• Hepatocyte Stress Increases Expression of Yes‐Associated Protein and Transcriptional Coactivator With PDZ‐Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis
  Hepatology, 2019
• Unexpected Rapid Increase in the Burden of NAFLD in China From 2008 to 2018: A Systematic Review and Meta‐Analysis
  Hepatology, 2019
• Should we undertake surveillance for HCC in patients with NAFLD?
  Journal of Hepatology, 2018
• Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
  Cell Metabolism, 2016
• RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion
  Tumor Biology, 2015
• The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
  Journal of Hepatology, 2015
• The Crumbs Complex Couples Cell Density Sensing to Hippo-Dependent Control of the TGF-β-SMAD Pathway
  Developmental Cell, 2010
• YAP1 Increases Organ Size and Expands Undifferentiated Progenitor Cells
  Current Biology, 2007
• Costimulation by Extracellular Matrix Proteins Determines the Response to TCR Ligation
  Cellular Immunology, 2001